TITLE:
Frequency of Cervix Dysplasia in Women with Prolapsed Uterus: Cross-Sectional Descriptive Study at Panzi General Referral Hospital
AUTHORS:
Nadine Neema Rukunghu, Olivier Nyakio, Eloge Ilunga-Mbaya, Chasinga Baharanyi Tchass, Kongwa Madoli, Dieudonné Kakusu, Julien Bwama Botalatala, Eric Munguakonkwa Ntagereka, Denis Mukwege
KEYWORDS:
Cervical Dysplasia, Uterine Prolapse, Panzi General Hospital, DRC
JOURNAL NAME:
Open Journal of Obstetrics and Gynecology,
Vol.13 No.7,
July
18,
2023
ABSTRACT: Introduction: According to the WHO (January 7, 2022), cervical
cancer is the second leading cause of cancer death worldwide among women of
childbearing age. However, cervical cancer is highly preventable and treatable
due to its well-known disease history which
goes through several detectable pre-cancerous phases with available
treatments. There are very few data on the prevalence of dysplastic lesions of
the cervix in the Democratic Republic of the Congo. Panzi General Referral Hospital is a care center for women with genital prolapse, and our study aimed to determine the prevalence of
dysplastic lesions of the cervix in this particular population. Methodology: This is a cross-sectional study of all women aged ≥ 18 years who consulted at the HGR Panzi from September
01 to December 31, 2022, diagnosed with uterine prolapse and who consented to
the study. Results: The mean (±SD) age of the patients was 47.44
(±14.42) years and the majority (67.7%) of them were aged 40 and over. For all
of the respondents, the Pap smear was normal in 62.6% and inflammatory in 2% of
cases, while cytological abnormalities, which were found in 35.4% of cases, including 12.1% of lesions high-grade
dysplastic (HSIL), i.e. 12 out
of a total of 99 women examined. Conclusion: Women with uterine prolapse
are twice as likely to develop dysplastic lesions as the general female
population. A screening and management program for these lesions is essential
in our preoperative protocol at the HGR Panzi and at the national level in
general.